☆ 4.5 Editorial Material

How worthwhile is methylene blue as a treatment of malaria?

EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2019)

Get Full Text
Add to Collection

Journal

EXPERT REVIEW OF ANTI-INFECTIVE THERAPY
Volume 17, Issue 7, Pages 471-473

Publisher

TAYLOR & FRANCIS LTD
DOI: 10.1080/14787210.2019.1634545

Keywords

Plasmodium falciparum; methylene blue; triple therapy; prevention of artemisinin resistance; malaria elimination

Categories

Infectious Diseases Microbiology Pharmacology & Pharmacy

Funding

  1. BASF (Germany)

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.